LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
This Quarter Return
+9.56%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$812M
AUM Growth
+$812M
(+37%)
Cap. Flow
+$175M
Cap. Flow
% of AUM
21.52%
Top 10 Holdings %
Top 10 Hldgs %
42.3%
Holding
3,119
New
216
Increased
1,250
Reduced
951
Closed
270
Top Buys
| 1 |
Vanguard Total International Stock ETF
VXUS
|
$10.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$8.62M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
$6.99M |
| 4 |
Axsome Therapeutics
AXSM
|
$6.52M |
| 5 |
Apple
AAPL
|
$5.79M |
Top Sells
| 1 |
iShares Russell 1000 Growth ETF
IWF
|
$1.3M |
| 2 |
MGI
MoneyGram International, Inc. New
MGI
|
$1.21M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$784K |
| 4 |
FLG
Flagstar Financial, Inc.
FLG
|
$512K |
| 5 |
Boston Scientific
BSX
|
$461K |
Sector Composition
| 1 | Financials | 17.72% |
| 2 | Technology | 11.12% |
| 3 | Healthcare | 9.24% |
| 4 | Industrials | 3.53% |
| 5 | Consumer Staples | 3.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Amazon
AMZN
$2.44T
| $4.62M | 0.57% | 54,911 -1,858 | -3% | -$156K |
|
27
Thermo Fisher Scientific
TMO
$186B
| $4.62M | 0.57% | 8,384 +7,473 | +820% | +$4.12M |
|
28
Oramed Pharmaceuticals
ORMP
$90.2M
| $4.61M | 0.57% | +383,351 | New | +$4.61M |
|
29
Invesco DB Commodity Index Tracking Fund
DBC
$1.27B
| $4.54M | 0.56% | +184,095 | New | +$4.54M |
|
30
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $4.54M | 0.56% | 60,856 +60,490 | +16,527% | +$4.51M |
|
31
First Trust Global Tactical Commodity Strategy Fund
FTGC
$2.23B
| $4.45M | 0.55% | 181,650 +175,150 | +2,695% | +$4.29M |
|
32
New Mountain Finance
NMFC
$1.13B
| $4.35M | 0.54% | +351,648 | New | +$4.35M |
|
33
Intuit
INTU
$186B
| $4.33M | 0.53% | 11,116 +9,617 | +642% | +$3.74M |
|
34
JPMorgan Chase
JPM
$829B
| $4.3M | 0.53% | 32,088 +2,400 | +8% | +$322K |
|
35
CME Group
CME
$96B
| $4.21M | 0.52% | 25,036 +4,430 | +21% | +$745K |
|
36
iShares US Industrials ETF
IYJ
$1.73B
| $4.2M | 0.52% | +43,582 | New | +$4.2M |
|
37
Estee Lauder
EL
$33B
| $4.2M | 0.52% | 16,940 +504 | +3% | +$125K |
|
38
iShares Core S&P 500 ETF
IVV
$662B
| $4.2M | 0.52% | 10,927 +4,524 | +71% | +$1.74M |
|
39
iShares US Oil & Gas Exploration & Production ETF
IEO
$483M
| $4.15M | 0.51% | +44,673 | New | +$4.15M |
|
40
Pfizer
PFE
$141B
| $4.1M | 0.5% | 79,984 +5,285 | +7% | +$271K |
|
41
Vanguard Mid-Cap ETF
VO
$87.5B
| $4.02M | 0.49% | 19,705 +620 | +3% | +$126K |
|
|
CHI
42
Calamos Convertible Opportunities and Income Fund
CHI
$812M
| $4M | 0.49% | 380,214 +370,214 | +3,702% | +$3.89M |
|
43
iShares Semiconductor ETF
SOXX
$13.6B
| $3.94M | 0.49% | 11,322 +10,556 | +1,378% | +$3.67M |
|
44
Alphabet (Google) Class C
GOOG
$2.58T
| $3.87M | 0.48% | 43,460 -1,799 | -4% | -$160K |
|
45
iShares Core S&P Small-Cap ETF
IJR
$85.2B
| $3.77M | 0.46% | 39,872 +613 | +2% | +$58K |
|
46
SPDR S&P Biotech ETF
XBI
$5.07B
| $3.75M | 0.46% | +45,168 | New | +$3.75M |
|
|
47
Alphabet (Google) Class A
GOOGL
$2.57T
| $3.72M | 0.46% | 42,158 +1,895 | +5% | +$167K |
|
48
Invesco Aerospace & Defense ETF
PPA
$6.22B
| $3.71M | 0.46% | +47,369 | New | +$3.71M |
|
49
NovoCure
NVCR
$1.38B
| $3.69M | 0.45% | 50,354 +50,183 | +29,347% | +$3.68M |
|
50
Vanguard S&P 500 ETF
VOO
$726B
| $3.34M | 0.41% | 9,512 +21 | +0.2% | +$7.38K |
|